Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-01-16

Clinical Trial Update: PPROM Erythromycin Versus Azithromycin

View source ↗

Summary

A clinical trial comparing erythromycin to azithromycin for preterm premature rupture of membranes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azithromycin (azithromycin)
  • ERYTHROMYCIN (ERYTHROMYCIN)

Snippet

Sponsor: University of Oklahoma | Conditions: Preterm Premature Rupture of Membranes | Status: COMPLETED